{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:42:18Z","timestamp":1787701338872,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04746-y","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T06:18:05Z","timestamp":1770445085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety analysis of different treatment schemes of erythropoiesis-stimulating agents for chronic kidney disease with anemia: a meta analysis between 2000\u20132024"],"prefix":"10.1186","volume":"27","author":[{"given":"Ruilin","family":"Ou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SuZhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhentao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"4746_CR1","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898[J]","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ, Lasserson T, Li T, Ly A, Marlin N, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898[J].","journal-title":"BMJ"},{"key":"4746_CR2","unstructured":"Review Manager (RevMan) [computer program]. Version 5.4. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2020[J]."},{"key":"4746_CR3","first-page":"2408","volume":"16","author":"H Zanwei","year":"2007","unstructured":"Zanwei H, Xiaolan F. Observation on the efficacy of high-dose erythropoietin in the treatment of renal anemia. Mod Med Health. 2007;16:2408\u201309.","journal-title":"Mod Med Health"},{"key":"4746_CR4","first-page":"24","volume":"21","author":"C Yan","year":"2008","unstructured":"Yan C, Dongsheng J. Observation on the efficacy of high-dose erythropoietin treatment for renal anemia. Mod Chin Drug App. 2008;21:24\u201326.","journal-title":"Mod Chin Drug App"},{"issue":"9","key":"4746_CR5","first-page":"807","volume":"10","author":"H Huiwen","year":"2009","unstructured":"Huiwen H, Xiurong X. Observation on the efficacy of high-dose recombinant erythropoietin pulse therapy for renal anemia. Chin J Integr Tradit West Nephrol. 2009;10(9):807\u201308.","journal-title":"Chin J Integr Tradit West Nephrol"},{"issue":"1","key":"4746_CR6","first-page":"20","volume":"11","author":"W Shaoting","year":"2009","unstructured":"Shaoting W, Ge W. Observation on the efficacy of different doses of recombinant human erythropoietin in the treatment of renal anemia. Chin Com Phy (Med Prof Semi-Mon). 2009;11(1):20.","journal-title":"Chin Com Phy (Med Prof Semi-Mon)"},{"issue":"3","key":"4746_CR7","first-page":"45","volume":"10","author":"X Min","year":"2010","unstructured":"Min X, Jingkui L, Zhixia W. Observation on the efficacy of high-dose recombinant human erythropoietin in the treatment of renal anemia. Practical Clin Int Chin West Med. 2010;10(3):45\u201346.","journal-title":"Practical Clin Int Chin West Med"},{"issue":"5","key":"4746_CR8","first-page":"399","volume":"46","author":"X Yunxi","year":"2011","unstructured":"Yunxi X, Qiong J, Aimin Z, et al. Clinical controlled study on the use of high-dose, low-frequency recombinant human erythropoietin. Jiangxi Med J. 2011;46(5):399\u2013401.","journal-title":"Jiangxi Med J"},{"issue":"4","key":"4746_CR9","first-page":"96","volume":"26","author":"H Tongqing","year":"2012","unstructured":"Tongqing H, Jinqiang M, Yandan X, Hanhua C. Observation of the efficacy of high-dose recombinant human erythropoietin in the treatment of renal anemia in patients undergoing hemodialysis. Chin Primary Health Care. 2012;26(4):96\u201397.","journal-title":"Chin Primary Health Care"},{"key":"4746_CR10","first-page":"15","volume":"24","author":"Q Yang","year":"2015","unstructured":"Yang Q, Hui J, Yuemei Z. Clinical observational study on the use of large doses and low frequency of recombinant human erythropoietin. Chin Rural Health. 2015;24:15.","journal-title":"Chin Rural Health"},{"key":"4746_CR11","first-page":"30","volume":"24","author":"L Xiuwen","year":"2018","unstructured":"Xiuwen L, Wen J. Observation on the efficacy of different doses of erythropoietin in the treatment of renal anemia in the Urumqi Area. Chin Foreign Women\u2019s Health Res. 2018;24:30\u201368.","journal-title":"Chin Foreign Women\u2019s Health Res"},{"issue":"13","key":"4746_CR12","first-page":"21","volume":"16","author":"J Luojia","year":"2019","unstructured":"Luojia J, Fengping Z, Junxia C, Gang L, Xiaoran F, Guoping Q. The effect of erythropoietin on hemoglobin and hematocrit in patients with renal anemia. Drug Eval. 2019;16(13):21\u201323.","journal-title":"Drug Eval"},{"issue":"12","key":"4746_CR13","first-page":"69","volume":"13","author":"G Zhenhua","year":"2020","unstructured":"Zhenhua G. Comparative study on the effects of different doses of recombinant human erythropoietin in renal anemia of maintenance hemodialysis. J Clin Ration Drug Use. 2020;13(12):69\u201370.","journal-title":"J Clin Ration Drug Use"},{"issue":"6","key":"4746_CR14","first-page":"711","volume":"26","author":"W Xiuling","year":"2023","unstructured":"Xiuling W, Jianjun L, Ying Y, et al. A study on the safety of medium-dose recombinant human erythropoietin injection administered weekly once versus multiple times in treating renal anemia in maintenance hemodialysis patients. Chin Gener Pract. 2023;26(6):711\u201317.","journal-title":"Chin Gener Pract"},{"key":"4746_CR15","first-page":"1209","volume":"7","author":"Z Qisheng","year":"2006","unstructured":"Qisheng Z, Boliang C, Huihua W. Clinical observation of high-dose erythropoietin treatment for renal anemia. Chin J Trop Med. 2006;7:1209\u201310.","journal-title":"Chin J Trop Med"},{"key":"4746_CR16","first-page":"1944","volume":"11","author":"X Lamei","year":"2006","unstructured":"Lamei X, Yongzhi X, Deshen T. Clinical observation and nursing of high-dose erythropoietin treatment for renal anemia. J Pract Med Tech. 2006;11:1944\u201345.","journal-title":"J Pract Med Tech"},{"key":"4746_CR17","first-page":"977","volume":"8","author":"F Deyue","year":"2005","unstructured":"Deyue F, Zhixi P, Jinquan W. Efficacy and cost analysis of recombinant erythropoietin in the treatment of anemia in chronic renal failure. Chin Primary Health Care. 2005;8:977\u201378.","journal-title":"Chin Primary Health Care"},{"key":"4746_CR18","first-page":"1009","volume":"13","author":"Z Ping","year":"2005","unstructured":"Ping Z, Jinsong L. Observation on the efficacy of high-dose erythropoietin in the treatment of renal anemia. Chin Pharm. 2005;13:1009\u201310.","journal-title":"Chin Pharm"},{"key":"4746_CR19","first-page":"49","volume":"3","author":"G Suqin","year":"2005","unstructured":"Suqin G, Junsheng Z, Jinyu L. Observation on the efficacy of high-dose erythropoietin in the treatment of renal anemia. Clin Med. 2005;3:49\u201350.","journal-title":"Clin Med"},{"key":"4746_CR20","first-page":"1243","volume":"11","author":"W Jun","year":"2002","unstructured":"Jun W, Zhizhong Y, Chaoyang Y, Yubin L, Linlin S, Changlin M. Observation on the efficacy of high-dose recombinant human erythropoietin in the treatment of uremic anemia. J Second Mil Med Univ. 2002;11:1243\u201345.","journal-title":"J Second Mil Med Univ"},{"issue":"11","key":"4746_CR21","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.2215\/CJN.03470509","volume":"4","author":"PE Pergola","year":"2009","unstructured":"Pergola PE, Gartenberg G, Fu M, Wolfson M, Rao S, Bowers P. A randomized controlled study of weekly and biweekly dosing of epoetin alfa in CKD patients with anemia. Clin J Am Soc Nephrol. 2009;4(11):1731\u201340.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"4746_CR22","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1093\/ndt\/gfn255","volume":"23","author":"YK Lee","year":"2008","unstructured":"Lee YK, Kim SG, Seo JW, et al. A comparison between once-weekly and twice- or thrice-weekly subcutaneous injection of epoetin alfa: results from a randomized controlled multicentre study. Nephrol Dial Transpl. 2008;23(10):3240\u201346.","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"4746_CR23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1053\/j.ajkd.2006.05.030","volume":"48","author":"G Mircescu","year":"2006","unstructured":"Mircescu G, G\u00e2rneat\u0103 L, Cioc\u00e2lteu A, et al. Once-every-2-weeks and once-weekly epoetin beta regimens: equivalency in hemodialyzed patients. Am J Kidney Dis. 2006;48(3):445\u201355.","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"4746_CR24","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1093\/ndt\/15.12.2014","volume":"15","author":"LG Weiss","year":"2000","unstructured":"Weiss LG, Clyne N, Divino Fihlho J, Frisenette-Fich C, Kurkus J, Svensson B. The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin beta: results from a randomized controlled multicentre trial. Swed Study Group Nephrol Dial Transpl. 2000;15(12):2014\u201319.","journal-title":"Swed Study Group Nephrol Dial Transpl"},{"issue":"6","key":"4746_CR25","first-page":"441","volume":"23","author":"X Jian","year":"2024","unstructured":"Jian X, Dongyun J, Pingping L, Lei C. Observation of hemoglobin variability in hemodialysis anemia treated with dapiprant \u03b1. Chin Blood Purif. 2024;23(6):441\u201344.","journal-title":"Chin Blood Purif"},{"issue":"1","key":"4746_CR26","first-page":"59","volume":"8","author":"N Chen","year":"2022","unstructured":"Chen N, Xing C, Niu J, et al. Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure: a randomized, open-label, parallel-group, non-inferiority phase III trail. Chronic Dis Transl Med. 2022;8(1):59\u201370.","journal-title":"Chronic Dis Transl Med"},{"issue":"1","key":"4746_CR27","first-page":"62","volume":"67","author":"KS Mehta","year":"2019","unstructured":"Mehta KS, Sinha SD, Vamsi B, et al. Darbepoetin alfa versus erythropoietin alfa for treatment of renal anemia in patients with chronic kidney disease at the Pre-dialysis Stage: a randomized non-inferiority trial. J Assoc Phys India. 2019;67(1):62\u201366.","journal-title":"J Assoc Phys India"},{"issue":"1","key":"4746_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12882-019-1209-1","volume":"20","author":"SD Sinha","year":"2019","unstructured":"Sinha SD, Bandi VK, Bheemareddy BR, et al. Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial. BMC Nephrol. 2019;20(1):90.","journal-title":"BMC Nephrol"},{"issue":"11","key":"4746_CR29","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0929-6646(08)60200-4","volume":"107","author":"WY Li","year":"2008","unstructured":"Li WY, Chu TS, Huang JW, Wu MS, Wu KD. Randomized study of darbepoetin alfa and recombinant human erythropoietin for treatment of renal anemia in chronic renal failure patients receiving peritoneal dialysis. J Formos Med Assoc. 2008;107(11):843\u201350.","journal-title":"J Formos Med Assoc"},{"issue":"5","key":"4746_CR30","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1067\/mcp.2002.128374","volume":"72","author":"M Allon","year":"2002","unstructured":"Allon M, Kleinman K, Walczyk M, et al. Pharmacokinetics and pharmacodynamics of darbepoetin alfa and epoetin in patients undergoing dialysis. Clin Pharmacol Ther. 2002;72(5):546\u201355.","journal-title":"Clin Pharmacol Ther"},{"issue":"2 Suppl 1","key":"4746_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0272-6386(93)70178-2[J]","volume":"22","author":"NI Ashai","year":"1993","unstructured":"Ashai NI, Paganini EP, Wilson JM. Intravenous versus subcutaneous dosing of epoetin: a review of the literature. Am J Kidney Dis. 1993;22(2 Suppl 1):23\u201331. https:\/\/doi.org\/10.1016\/0272-6386(93)70178-2[J].","journal-title":"Am J Kidney Dis"},{"key":"4746_CR32","doi-asserted-by":"crossref","unstructured":"Allon M, et al. Pharmacokinetics and pharmacodynamics of darbepoetin alfa and epoetin in patients undergoing dialysis. Clin Pharmacol Ther. 2002","DOI":"10.1067\/mcp.2002.128374"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04746-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04746-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04746-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T10:39:29Z","timestamp":1773225569000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04746-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4746"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04746-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a meta-analysis based on previously published literature. All data were extracted from publicly available research articles. No original data collection or direct involvement of human or animal subjects was conducted, and therefore, ethical approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"166"}}